Table 1. Clinicopathological characteristics of HCC patients in TCGA (n=371).
| Characteristics | n | % |
|---|---|---|
| Age [mean (SD)] | 59.66 | 13.35 |
| Sex (%) | 251 | |
| Male | 251 | 67.7 |
| Female | 120 | 32.3 |
| Grade (%) | ||
| G1 | 55 | 14.8 |
| G2 | 178 | 48.0 |
| G3 | 120 | 32.3 |
| G4 | 13 | 3.5 |
| Unknown | 5 | 1.3 |
| Stage (%) | ||
| Stage I | 174 | 46.9 |
| Stage II | 85 | 22.9 |
| Stage III | 84 | 22.6 |
| Stage IV | 4 | 1.1 |
| Unknown | 24 | 6.5 |
| T (%) | ||
| T1 | 184 | 49.6 |
| T2 | 92 | 24.8 |
| T3 | 79 | 21.3 |
| T4 | 14 | 3.8 |
| Unknown | 2 | 0.5 |
| M (%) | ||
| M0 | 269 | 72.5 |
| M1 | 3 | 0.8 |
| MX | 99 | 26.7 |
| N (%) | ||
| N0 | 253 | 68.2 |
| N1 | 4 | 1.1 |
| NX | 113 | 30.5 |
| Unknown | 1 | 0.3 |
HCC, hepatocellular carcinoma; TCGA, The Cancer Genome Atlas.